close
This ad will auto close in 10 seconds
Sun Pharma, Samsung BioLogics ink $55.5 mn pact

Sun Pharma, Samsung BioLogics ink $55.5 mn pact

As per the pact, Sun Pharma has appointed Samsung BioLogics to manufacture Tildrakizumab.

Sun Pharma shares hit 52-week low, tank over 13%

Sun Pharma shares hit 52-week low, tank over 13%

Shares of Sun Pharma on Monday crashed by over 13 percent after the company reported a 14 percent decline in consolidated net profit for the fourth quarter ended March.

Investor wealth surges over Rs 50 lakh crore in 3 years

Investor wealth surges over Rs 50 lakh crore in 3 years

Investor wealth has surged by over Rs 50 lakh crore since the Modi government was voted to power three years ago, with the Sensex surging to its lifetime high of 31,074.07 on Friday.

USFDA issues 11 observations for Sun Pharma's Dadra facility

USFDA issues 11 observations for Sun Pharma's Dadra facility

Drug major Sun Pharmaceutical Industries has received 11 observations from the US health regulator after inspection of its Dadra facility.

Sun Pharma shares down 3%; m-cap dips by Rs 5,004 crore

Sun Pharma shares down 3%; m-cap dips by Rs 5,004 crore

Shares of Sun Pharma fell by 3 percent today amid reports of USFDA inspection at one of the company's plant.

USFDA to lift import alert on Sun Pharma's Mohali plant

USFDA to lift import alert on Sun Pharma's Mohali plant

The US health regulator has proposed to lift the import alert on Sun Pharma's Mohali (Punjab) based manufacturing plant.

Sun Pharma subsidiary invests 14.6% stake in US company for $13 million

Sun Pharma subsidiary invests 14.6% stake in US company for $13 million

Pharamceutical major Sun Pharma's subsidiary has invested USD 13 million (about Rs 88 crore) in the US-based scPharmaceuticals Inc, announced the company on Friday.

Sun Pharma to acquire oncology product from Novartis for $175 million

Sun Pharma to acquire oncology product from Novartis for $175 million

Drug major Sun Pharmaceutical Industries on Thursday said it it will acquire a branded oncology product, Odomzo, from Novartis for an upfront payment of USD 175 million.

Sun Pharma acquires Ocular Technologies Sarl

Sun Pharma acquires Ocular Technologies Sarl

Pharmaceutical major Sun Pharma has informed BSE that it has completed the acquisition of the US-based eye care specialist Ocular Technologies Sarl.

Sun Pharma to acquire 85% stake in Russia's Biosintez

Sun Pharma to acquire 85% stake in Russia's Biosintez

The country's largest drug firm Sun Pharma on Wednesday said it has signed definitive agreements to acquire 85.1 percent stake in Russia-based JSC Biosintez for USD 24 million.

Sun Pharma buys back Rs 675 crore shares

Sun Pharma buys back Rs 675 crore shares

 Sun Pharma today said it has completed buyback of shares worth Rs 675 crore to return surplus funds to its shareholders.

Sun Pharma gets clearance for buyback from SEBI

Sun Pharma gets clearance for buyback from SEBI. Watch this special segment and get to know more here.

Sun Pharma inks distribution alliance with Mitsubishi Tanabe

Sun Pharma inks distribution alliance with Mitsubishi Tanabe

New Delhi:Drug major Sun Pharma has announced initiation of a phased transfer of manufacturing and marketing rights of 14 brands, it acquired from Swiss drug firm Novartis in Japan, earlier this year for USD 293 million.

Lupin Pharmaceuticals is India's most reputed pharma brand; Sun Pharma second

Lupin Pharmaceuticals is India's most reputed pharma brand; Sun Pharma second

Mumbai-based Lupin Pharmaceuticals is India`s most reputed pharmaceutical brand, said a report by Bluebytes, a leading media-analytics company on Wednesday.

Sun Pharma Q1 net zooms over 3-fold

Sun Pharma Q1 net zooms over 3-fold

Share Bazar, Mandi Live, Aap Ka Bazar, First Trade, Big Debate etc.

Sun Pharma Q1 net zooms over 3-fold to Rs 2,033.71 crore

Sun Pharma Q1 net zooms over 3-fold to Rs 2,033.71 crore

Sun Pharmaceutical Industries' consolidated net profit zoomed more than 3-fold to Rs 2,033.71 crore for the first quarter ended June 30, 2016-17, on account of robust sales.

 TCS, Infosys in Forbes 'Super 50' list; Tata Motors, HUL dropped

TCS, Infosys in Forbes 'Super 50' list; Tata Motors, HUL dropped

Software majors TCS and Infosys, pharma giants Sun Pharma and Lupin and private sector lenders HDFC Bank and Axis Bank feature in Forbes India's Super 50 List this year, while biggies like Tata Motors and HUL have been dropped.

Top 8 companies add Rs 57,965 crore in m-cap, HDFC Bank gains most

Top 8 companies add Rs 57,965 crore in m-cap, HDFC Bank gains most

The combined market valuation of eight of the top 10 most valued Indian companies surged by Rs 57,965.56 crore last week amid a positive broader market trend.

Sun Pharma launches sunscreen brand Suncros

Sun Pharma launches sunscreen brand Suncros

New Delhi: Drug major Sun Pharmaceutical Industries on Wednesday announced the launch of its sunscreen brand 'Suncros' through the company's Global Consumer Healthcare business vertical.

Soon, a botanical drug to cure dengue!

Sun Pharma has signed an agreement with the International Centre for Genetic Engineering and Biotechnology to develop a novel plant-based drug to combat the dengue.